Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Cidara Therapeutics, Inc.
| Metric | Cidara Therapeutics, Inc. CDTXHealthcare |
|---|---|
| Quality Score | 35 / 100 |
| Revenue (latest) | $1M |
| Net income (latest) | −$170M |
| Operating margin | −13811.9% |
| Net margin | −13319.8% |
| Return on equity | −104.0% |
| Return on assets | −79.1% |
| Return on capital (ROCE) | −106.6% |
| Debt / equity | 0.32× |
| Revenue growth (YoY) | −13.1% |
| Altman Z″ (distress) | -6.53 |
| Accruals / assets | 3.1% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.